Microgel particulate adjuvant: characterisation and mechanisms of action

Procedia in Vaccinology

Volumn 2, Issue 1, 2010, Pages 12-16

  Vialle, R ^a   Dupuis, L ^b   Deville, S ^b   Bertrand, F ^b   Gaucheron, J ^c   Aucouturier, J ^b  

^a SEPPIC ^*  (Singapore)

^b SEPPIC   (France)

^c SEPPIC   (France)

Author keywords

Adjuvant; Mechanism of action; Montanide Gel 01; Polymer; Safety; Veterinary adjuvant

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; MONTANIDE GEL 01; SUPERFOSS; UNCLASSIFIED DRUG;

CALIBRATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ADSORPTION; DRUG MECHANISM; DRUG SAFETY; GEL; GUINEA PIG; IMMUNE RESPONSE; INJECTION SITE; ISOELECTRIC POINT; NONHUMAN; PARTICULATE MATTER; POLYMERIZATION; PRIORITY JOURNAL; SYNTHESIS;

EID: 77950645315     PISSN: 1877282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.provac.2010.03.003     Document Type: Conference Paper

References (10)

1. Aucouturier J., Deville S., Perret C., Vallée I., and Boireau P. Assessment of efficacy and safety of various adjuvant formulations with a total soluble extract of Trichinella spiralis. Parasite. 8 2 Suppl (2001 Jun) S126-S132
2. Audibert A.C., and Lise L.D. Adjuvants: current status, clinical perspectives and future prospects. Immunol Today Jun 14 6 (1993) 281-284
3. Cox J.C., and Coulter A.R. Adjuvants: a classification and review of their mode of action. Vaccine 15 (1997) 248-256
4. Day M.J., Schoon H.A., Magnol J.P., Saik J., Devauchelle P., Truyen U., Gruffydd-Jones T.J., Cozette V., Jas D., Poulet H., Pollmeier M., and Thibault J.C. A kinetic study of histopathological changes in the subcutis of cats injected with non-adjuvanted and adjuvanted multi-component vaccines. Vaccine 25 20 (2007 May 16) 4073-4084
5. Deville S., Parker R., Laval A. Adjuvant formulation for Influenza H1N1 and H3N2 pig vaccines: Montanide™ Gel safety and efficacy study. Proceedings of the Conference of Research of Workers in Animal Diseases 2008, Chicago.
6. Dupuis L., Deville S., Bertrand F., Laval A., Aucouturier J. Adjuvant formulation for multivalent pig vaccines: Pasteurella multocida anatoxins and inactivated Bordetella bronchiseptica, Montanide™ Gel safety study. Proceedings of the International pig veterinary society 2008, Durban.
7. HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine 20 Suppl. 3 (2002) S34-S39 Review
8. Lindblad E.B. Aluminium adjuvants-in retrospect and prospect. Vaccine 22 27-28 (2004 Sep 9) 3658-3668
9. Oda K., Tsukahara F., Kubota S., Kida K., Kitajima T., and Hashimoto S. Emulsifier content and side effects of oil-based adjuvant vaccine in swine. Research in Veterinary Science 81 (2006) 51-57
10. Parker R., Deville S., Dupuis L., Bertrand F., and Aucouturier J. Adjuvant formulation for veterinary vaccines: Montanide™ Gel safety profile. Procedia in Vaccinology 1 1 (2009) 140-147